Search | Page 6 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Thrombopoiesis-stimulating agents and myelodysplastic syndromes

    ... Thrombocytopenia in patients with myelodysplastic syndromes (MDS) is a frequent cause of haemorrhage-related morbidity and ...

    Research Article last updated 07/20/2018 - 5:15pm.

  2. Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion

    ... on long-term outcomes of patients with lower risk myelodysplastic syndromes (MDS) and chromosome 5q deletion (del(5q)) is unclear. This ...

    Research Article last updated 07/20/2018 - 5:15pm.

  3. Combination of Azacitidine and Lenalidomide in Myelodysplastic Syndromes or acute Myeloid Leukemia-a wise Liaison?

    ... Treatment options for older patients with advanced myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) are limited and the ...

    Research Article last updated 07/20/2018 - 5:15pm.

  4. Integrating genetics and epigenetics in myelodysplastic syndromes: advances in pathogenesis and disease evolution

    ... The myelodysplastic syndromes (MDS) are a group of clonal diseases characterized by ...

    Research Article last updated 07/20/2018 - 5:15pm.

  5. Evaluation of epidemiological factors in survival of patients with de novo myelodysplastic syndromes

    ... Myelodysplastic syndromes (MDS) prognosis is currently based solely on clinical ...

    Research Article last updated 07/20/2018 - 5:15pm.

  6. Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes

    ... has allowed for the detection of somatic mutations in myelodysplastic syndromes (MDS), the clinical relevance of variant allele frequency (VAF) ...

    Research Article last updated 07/20/2018 - 5:15pm.

  7. Transplantation for myelodysplastic syndromes 2013.

    ... only current treatment capable of curing patients with myelodysplastic syndromes (MDS) is allogeneic haematopoietic stem cell transplantation ...

    Research Article last updated 07/20/2018 - 5:15pm.

  8. Impact of tobacco usage on disease outcome in myelodysplastic syndromes

    ... is an independent prognostic factor in patients with myelodysplastic syndromes (MDS). To evaluate the impact of tobacco usage in this ...

    Research Article last updated 07/20/2018 - 5:15pm.

  9. A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure

    ... after azacitidine (AZA) failure in higher-risk myelodysplastic syndromes (MDS) is poor and new treatment options are needed. Erlotinib, an ...

    Research Article last updated 07/20/2018 - 5:15pm.

  10. MicroRNAs in the pathogenesis of myelodysplastic syndromes and myeloid leukaemia

    ... in the pathogenesis of the stem cell disorder myelodysplastic syndromes and myeloid leukaemia. SUMMARY: Improved understanding ...

    Research Article last updated 07/20/2018 - 5:15pm.